Nouroozzadeh J, Tajaddinisarmadi J, Wolff SP
Journal of Clinical Gastroenterology
It combines the effects of GLP-1 agonism with those of GIP, potentially offering additional benefits: - Enhanced insulin secretion and sensitivity - Greater appetite suppression - Improved lipid metabolism - Potential direct effects on adipose tissue[1] This dual action may explain why tirzepatide has shown superior efficacy in clinical trials, demonstrating greater reductions in HbA1c levels and body weight compared to existing therapies, including semaglutide[4]
Eat Balanced, Small Meals Even with reduced appetite, focus on nutrient-rich foods
Provides a custom program, remote monitoring instruments, and coaching on a bi-weekly basis
doi: 10.1016/j.tibtech.2013.12.004 58 HatamiF.ManifarS.Asghari-PaskiabiF.Bagheri AmiriF.NojoumiS